28 related articles for article (PubMed ID: 2209670)
1. The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease.
Krashia P; Spoleti E; D'Amelio M
Front Psychiatry; 2022; 13():1039725. PubMed ID: 36325523
[TBL] [Abstract][Full Text] [Related]
2. Differential Influence of Amyloid-β on the Kinetics of Dopamine Release in the Dorsal and Ventral Striatum of Rats.
Mukhin VN; Borovets IR; Sizov VV; Pavlov KI; Klimenko VM
Neurotox Res; 2021 Aug; 39(4):1285-1292. PubMed ID: 33991320
[TBL] [Abstract][Full Text] [Related]
3. Catecholamines in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Pan X; Kaminga AC; Jia P; Wen SW; Acheampong K; Liu A
Front Aging Neurosci; 2020; 12():184. PubMed ID: 33024430
[No Abstract] [Full Text] [Related]
4. Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.
Barilar JO; Knezovic A; Perhoc AB; Homolak J; Riederer P; Salkovic-Petrisic M
J Neural Transm (Vienna); 2020 Feb; 127(2):231-250. PubMed ID: 32030485
[TBL] [Abstract][Full Text] [Related]
5. Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis.
Pan X; Kaminga AC; Wen SW; Wu X; Acheampong K; Liu A
Front Aging Neurosci; 2019; 11():175. PubMed ID: 31354471
[No Abstract] [Full Text] [Related]
6. Monoaminergic System Modulation in Depression and Alzheimer's Disease: A New Standpoint?
Morgese MG; Trabace L
Front Pharmacol; 2019; 10():483. PubMed ID: 31156428
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions for apathy in Alzheimer's disease.
Ruthirakuhan MT; Herrmann N; Abraham EH; Chan S; Lanctôt KL
Cochrane Database Syst Rev; 2018 May; 5(5):CD012197. PubMed ID: 29727467
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease.
Yan R; Fan Q; Zhou J; Vassar R
Neurosci Biobehav Rev; 2016 Jun; 65():326-40. PubMed ID: 27044452
[TBL] [Abstract][Full Text] [Related]
9. "Is dopamine involved in Alzheimer's disease?".
Martorana A; Koch G
Front Aging Neurosci; 2014; 6():252. PubMed ID: 25309431
[TBL] [Abstract][Full Text] [Related]
10. The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease.
Mitchell RA; Herrmann N; Lanctôt KL
CNS Neurosci Ther; 2011 Oct; 17(5):411-27. PubMed ID: 20560994
[TBL] [Abstract][Full Text] [Related]
11. Unchanged density of caudate nucleus dopamine uptake sites in depressed suicide victims.
Allard P; Norlén M
J Neural Transm (Vienna); 1997; 104(11-12):1353-60. PubMed ID: 9503281
[TBL] [Abstract][Full Text] [Related]
12. [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent.
Kung MP; Stevenson DA; Plössl K; Meegalla SK; Beckwith A; Essman WD; Mu M; Lucki I; Kung HF
Eur J Nucl Med; 1997 Apr; 24(4):372-80. PubMed ID: 9096087
[TBL] [Abstract][Full Text] [Related]
13. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT. Binding kinetics in the human brain.
Brücke T; Kornhuber J; Angelberger P; Asenbaum S; Frassine H; Podreka I
J Neural Transm Gen Sect; 1993; 94(2):137-46. PubMed ID: 8110440
[TBL] [Abstract][Full Text] [Related]
14. Imaging of serotonin and dopamine transporters in the living human brain.
Kuikka JT; Tiihonen J; Bergström KA; Karhu J; Hartikainen P; Viinamäki H; Länsimies E; Lehtonen J; Hakola P
Eur J Nucl Med; 1995 Apr; 22(4):346-50. PubMed ID: 7607266
[TBL] [Abstract][Full Text] [Related]
15. Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's disease.
Allard P; Alafuzoff I; Carlsson A; Eriksson K; Ericson E; Gottfries CG; Marcusson JO
Eur Neurol; 1990; 30(4):181-5. PubMed ID: 2209670
[TBL] [Abstract][Full Text] [Related]
16. Dopamine uptake sites in Parkinson's disease and in dementia of the Alzheimer type.
Allard PO; Rinne J; Marcusson JO
Brain Res; 1994 Feb; 637(1-2):262-6. PubMed ID: 8180805
[TBL] [Abstract][Full Text] [Related]
17. Age-correlated loss of dopamine uptake sites labeled with [3H]GBR-12935 in human putamen.
Allard P; Marcusson JO
Neurobiol Aging; 1989; 10(6):661-4. PubMed ID: 2628776
[TBL] [Abstract][Full Text] [Related]
18. [3H]GBR-12935 binding to dopamine uptake sites in the human brain.
Marcusson J; Eriksson K
Brain Res; 1988 Aug; 457(1):122-9. PubMed ID: 3167558
[TBL] [Abstract][Full Text] [Related]
19. Decreased densities of dopamine D1 receptors in the putamen and hippocampus in senile dementia of the Alzheimer type.
Cortés R; Probst A; Palacios JM
Brain Res; 1988 Dec; 475(1):164-7. PubMed ID: 2975188
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
